Skip to main content
Fig. 4 | Molecular Medicine

Fig. 4

From: A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire

Fig. 4

FACS analysis of CD8+ T cells from two melanoma patients treated with NDV oncolysates.Backgates on the CD8+CD57− (R1) and CD8+CD57+ (R2) T cell subsets show a marked difference in the frequency of cells carrying the Vβ 16 and Vβ 14 TCR in these two individuals.

Back to article page

Molecular Medicine

ISSN: 1528-3658